These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 2616992)
1. [Acute myeloid leukemia after treatment of Hodgkin's disease]. Carneiro PC; Pereira ED; Mitteldorf CS; Martinez GA; Beitler B; Pozzi DH Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(2):87-90. PubMed ID: 2616992 [TBL] [Abstract][Full Text] [Related]
2. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study. Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578 [TBL] [Abstract][Full Text] [Related]
3. Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia. Zinzani PL; Fiacchini M; Mazza P; Gherlinzoni F; Bocchia M; Tura S Haematologica; 1991; 76(4):305-10. PubMed ID: 1724437 [TBL] [Abstract][Full Text] [Related]
4. [Second neoplasms as a late complication of the treatment of Hodgkin's disease]. Morales MD; González FA; Villegas A; del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Colomé JA Sangre (Barc); 1992 Dec; 37(6):429-33. PubMed ID: 1293793 [TBL] [Abstract][Full Text] [Related]
5. [Non-Hodgkin's lymphoma secondary to Hodgkin's disease treated with chemo- and radiotherapy. Report of a case]. Gamboa Domínguez A; Pita Ramírez L; Hurtado Monroy R; Angeles-Angeles A Rev Invest Clin; 1992; 44(3):393-8. PubMed ID: 1283228 [TBL] [Abstract][Full Text] [Related]
6. Hodgkin's disease and the risk of acute leukemia in successfully treated patients. Valagussa P; Bonadonna G Haematologica; 1998 Sep; 83(9):769-70. PubMed ID: 9825571 [No Abstract] [Full Text] [Related]
7. Hodgkin's disease and acute leukemia. Is it a true association? Avilés A; Díaz-Maqueo JC; Ayala JR; Cortés HD; García EL Arch Med Res; 1992; 23(1):65-8. PubMed ID: 1308794 [TBL] [Abstract][Full Text] [Related]
8. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML. Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773 [TBL] [Abstract][Full Text] [Related]
9. [Acute leukemia in patients treated for Hodgkin's disease]. Boccaccio P; Rosa F; Casciaro S; D'Elia P; Romagnoli M; Ghio R Recenti Prog Med; 1988 Jan; 79(1):32-7. PubMed ID: 3375542 [No Abstract] [Full Text] [Related]
11. Immunoblastic lymphoma following therapy for Hodgkin's disease. A case report. Casini M; Pianezze G; Fabris P; Cemin S; Coser P Haematologica; 1986; 71(1):50-2. PubMed ID: 3084357 [No Abstract] [Full Text] [Related]
12. [Secondary malignant tumors following treatment of Hodgkin's disease]. Shishkin IP Med Radiol (Mosk); 1984 Aug; 29(8):24-8. PubMed ID: 6590941 [TBL] [Abstract][Full Text] [Related]
13. Analysis of the risk of solid tumor following Hodgkin's disease. Maurizi Enrici R; Anselmo AP; Osti MF; Santoro M; Tombolini V; Mandelli F; Biagini C Haematologica; 1997; 82(1):57-63. PubMed ID: 9107084 [TBL] [Abstract][Full Text] [Related]
14. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease. Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727 [TBL] [Abstract][Full Text] [Related]
15. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone. Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771 [TBL] [Abstract][Full Text] [Related]
16. [Myocardial infarct in a patient with Hodgkin's disease treated with cyclic polychemotherapy]. Matusewicz W; Drzewoski J; Robak T; Krykowski E Kardiol Pol; 1983; 26(7):591-4. PubMed ID: 6689036 [No Abstract] [Full Text] [Related]
17. [Acute non-lymphatic leukemia after treatment of Hodgkin's lymphoma with chemotherapy and radiotherapy]. Lira P; Grebe G Rev Med Chil; 1984 Oct; 112(10):1021-5. PubMed ID: 6085597 [No Abstract] [Full Text] [Related]
18. Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease. Villani F; Busia A; Villani M; Laffranchi A; Viviani S; Bonfante V Anticancer Res; 2009 Feb; 29(2):777-83. PubMed ID: 19331235 [TBL] [Abstract][Full Text] [Related]
19. Acute nonlymphocytic leukemia after radiation and MOPP chemotherapy for Hodgkin's disease. Lavey RS J Clin Oncol; 1990 Dec; 8(12):2089-90. PubMed ID: 2230901 [No Abstract] [Full Text] [Related]
20. Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease. Blayney DW; Longo DL; Young RC; Greene MH; Hubbard SM; Postal MG; Duffey PL; DeVita VT N Engl J Med; 1987 Mar; 316(12):710-4. PubMed ID: 3821809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]